Merck KGaA (Merck KGaA) Pre-Tax Income

: $3,751 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

Pretax income is the income that a company earns before paying income taxes. Merck KGaA's pretax income for the three months ended in Dec. 2023 was $699 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $3,751 Mil. Merck KGaA's pretax margin was 12.27%.

During the past 13 years, Merck KGaA's highest Pretax Margin was 19.93%. The lowest was 9.85%. And the median was 14.51%.

Merck KGaA Pre-Tax Income Historical Data

The historical data trend for Merck KGaA's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

1,927.78

3,199.51

4,433.90

4,541.31

3,799.35

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income																888.77	1,083.51	968.58	1,000.00	699.02

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck KGaA Pre-Tax Income Distribution

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Pre-Tax Income falls into.

Merck KGaA Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Merck KGaA's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	3900.763	+	0	+	-350.055	+	187.568	+	61.07
	=	3,799

Merck KGaA's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	599.782	+	0	+	-41.439	+	35.987	+	104.689
	=	699

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,751 Mil.

Merck KGaA (OTCPK:MKKGY) Pre-Tax Income Explanation

Merck KGaA's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	699.019	/	5697.928
	=	12.27%

During the past 13 years, Merck KGaA's highest Pretax Margin was 19.93%. The lowest was 9.85%. And the median was 14.51%.

Merck KGaA Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (Merck KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRK:Germany MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.